Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib) cream in adults with moderate atopic dermatitis ...
FDA Pre-New Drug Application (NDA) meeting granted for QTORIN™ rapamycin for the treatment of microcystic lymphatic ...
Tens of thousands of people living with the skin-lightening disorder vitiligo in the UK will soon be able to access an approved treatment for the first time. Reimbursement authority NICE has said that ...
Find one of 5 Origin PC promo codes to add to your order to save on custom-built gaming PCs, peripherals, accessories and more. All coupon content is created by PC Gamer. We may earn a commission if ...
FDA Pre-New Drug Application (NDA) meeting granted for QTORIN rapamycin for the treatment of microcystic lymphatic malformations, with meeting expected in second quarter of 2026; NDA submission on tra ...
What an early example of a dental bridge reveals about health, wealth and social values in the late medieval and early modern world May 8, 2026 5:32 p.m. Cool Finds Volcanic eruptions, climate change, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results